Braveheart Bio Inc. (BRVE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Braveheart Bio Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$21.76
−0.27% today
Market cap
$2.0B
Overall quality
52/100
Kronos AI 30-day
+5.0%
7 of 8 simulated paths end higher
Braveheart Bio Inc. (BRVE) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.0B. It trades at $21.76, down 0.27% today. Its overall quality score is 52 out of 100, ranked against the whole US market. 4 analysts' average target of $45.25 implies +108.0% from today's price. Kronos AI's 30-day forecast is +5.0% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $45.25 |
| Low – high | $40.00 – $48.00 |
| Analysts | 4 |
| Upside to average | +108.0% |
Kronos AI 30-day forecast
| Expected close | $22.91 (+5.0%) |
| Likely range | −0.6% … +9.8% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
| Profitability | 50 |
| Solvency | 63 |
| Growth | 44 |
| Overall | 52 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.